[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608980":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":31,"responsibleParty":47,"collaborators":49,"id":55,"slug":20,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":20,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":63,"enrollmentInfo":64,"targetDuration":20,"studyType":67,"phases":68,"briefSummary":70,"conditions":71,"keywords":73,"overallStatus":77,"whyStopped":20,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"TECLens, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment Group","EXPERIMENTAL","Open label treatment arm",[13],"Device: Quantitative refractive crosslinking",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Quantitative refractive crosslinking","Non-invasive corneal cross-linking device delivering controlled UV light through a contact lens platform for biomechanical stabilization of the cornea.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Patrick Lopath","CONTACT","919-824-5224","plopath@teclens.com",{"name":28,"role":24,"phone":29,"phoneExt":20,"email":30},"Ibrahim Seven","440-485-9091","ibrahim.seven@teclens.com",[32],{"facility":33,"status":20,"city":34,"state":35,"zip":20,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Asian Eye Institute","Makati City","Philippines",{"type":37,"coordinates":38},"Point",[39,40],121.03269,14.55027,{"lat":40,"lon":39},[43],{"name":44,"role":24,"phone":45,"phoneExt":20,"email":46},"Mary Ann Catacutan","632-8898-2019","mtcatacutan@asianeyeinstitute.com",{"type":48,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[50,53],{"name":51,"class":52},"Robert Ang, MD","UNKNOWN",{"name":54,"class":52},"Robert Ang, MD - Asian Eye Institute","100608980",false,"NCT07208604","Open Label, Multi-center, Phase I Study of TECLens Quantitative Refractive Crosslinking in Presbyopia-Aged Patients.","Open Label, Multi-center, Phase I Study of TECLens Corneal Crosslinking System for Correction of Refractive Error in Patients of Presbyopia Age.","Inclusion Criteria:\n\n* Adults aged 40-65 years\n* Healthy cornea\n* Refractive error between +4.0 D and -5.0 D\n* Phakic or monofocal pseudophakic (≥6 months post IOL placement)\n* Visual acuity correctable by ±0.25 D\n\nExclusion Criteria:\n\n* Corneal dystrophy, scarring, or prior corneal crosslinking\n* Astigmatism \\>1.0 D\n* Active ocular infection, inflammation, or uncontrolled dry eye\n* Advanced glaucoma or diabetic retinopathy\n* History of delayed corneal healing\n* Pregnancy, breastfeeding, or planning pregnancy during study period\n* Certain medications (e.g., isotretinoin)\n* Recent participation in other investigational drug\u002Fdevice studies (within 30 days)\n* Patients with uncontrolled dry eye or surface disease","ALL","40 Years","65 Years",{"count":65,"type":66},25,"ESTIMATED","INTERVENTIONAL",[69],"NA","An 'on-eye' UV delivery system for corneal crosslinking can be used safely and effectively to help free presbyopic patients from the need for reading glasses.",[72],"Presbyopia",[74,72,75,76],"Corneal crosslinking","Myopia","Hyperopia","NOT_YET_RECRUITING","2025-09-28",{"date":80,"type":81},"2025-10-06","ACTUAL",{"date":83,"type":66},"2025-09-30",{"date":85,"type":66},"2026-08",{"name":5,"class":6},1]